Examkin

Question

Difficulty: HardDiagnostic and Screening Test Performance

A clinical epidemiology task force is evaluating the statistical performance of various diagnostic and screening tests across different patient populations and under modified operational protocols. Match each operational change or epidemiological shift (left) with its expected direct effect on the statistical performance characteristics of the test (right).

  • Raising the cutoff concentration required for a continuous biomarker assay to be considered positiveDecreases sensitivity and negative predictive value (NPV); increases specificity and positive predictive value (PPV)
  • Lowering the optical density threshold required for a qualitative screening assay to be considered positiveIncreases sensitivity and negative predictive value (NPV); decreases specificity and positive predictive value (PPV)
  • Applying an established screening test in a specialized tertiary care clinic rather than a general outpatient settingIncreases positive predictive value (PPV); decreases negative predictive value (NPV); does not alter intrinsic sensitivity or specificity
  • Utilizing a diagnostic assay in a community following a highly effective eradication campaign that significantly reduced disease incidenceDecreases positive predictive value (PPV); increases negative predictive value (NPV); does not alter intrinsic sensitivity or specificity

Answer

1 matches with Decreasing sensitivity/NPV and increasing specificity/PPV. 2 matches with Increasing sensitivity/NPV and decreasing specificity/PPV. 3 matches with Increasing PPV and decreasing NPV with no change to intrinsic parameters. 4 matches with Decreasing PPV and increasing NPV with no change to intrinsic parameters.
Changes in test cutoffs directly alter intrinsic test parameters (sensitivity and specificity), which mathematically drive corresponding changes in predictive values based on the new rates of false positives and false negatives. Conversely, changes in population prevalence only alter the predictive values (PPV and NPV) due to shifts in the underlying true positive and true negative base rates, leaving intrinsic test parameters entirely unchanged.

Step-by-Step Solution

1
Analyze threshold shifts (Left 1 and Left 2)
Raising the threshold shifts the diagnostic line toward the diseased population, reducing false positives (improving specificity and PPV) but increasing false negatives (worsening sensitivity and NPV). Lowering the threshold does the exact opposite.
Test cutoffs directly alter the intrinsic parameters of the test (sensitivity and specificity) by reclassifying the overlapping populations of healthy and diseased individuals.
2
Analyze prevalence shifts (Left 3 and Left 4)
Moving to a tertiary clinic increases disease prevalence, which mathematically increases PPV and decreases NPV. A successful eradication campaign lowers disease prevalence, which decreases PPV and increases NPV.
Sensitivity and specificity are independent of disease prevalence. However, predictive values depend heavily on the pre-test probability (prevalence) of the population being tested.

Key Concept

The impact of diagnostic thresholds and disease prevalence on test sensitivity, specificity, and predictive values.
Estimated Time:2m 0s
Rate this question

Topics

Diagnostic and Screening Test Performance

More questions from this topic